Correlation Of Clinical Severity And Extent Of Disease With Colonic Malignancy Trends Over Time In Ulcerative Colitis: A Study From North Karnataka
Keywords:
Ulcerative colitis, Mayo score, Mayo Endoscopic Score, Pancolitis, Colitis-associated colorectal cancer, Inflammatory bowel disease, North Karnataka, Endoscopic severity, UC malignancy riskAbstract
Background: Ulcerative colitis (UC) is a chronic inflammatory bowel disease associated with variable clinical severity and an increased long-term risk of colorectal cancer (CRC), particularly in patients with extensive colonic involvement and persistent endoscopic inflammation. Indian data on long-term outcomes, especially malignancy risk, remain limited.
Aim: To evaluate the correlation between disease extent, Mayo endoscopic severity, and the development of colonic malignancy in a cohort of UC patients from North Karnataka.
Methods: A retrospective analysis was conducted on 122 UC patients over a 15-year period. Demographic characteristics, disease extent, clinical Mayo score, Mayo Endoscopic Score (MES), and CRC occurrence were recorded. UC diagnosis was confirmed by colonoscopy, contrast-enhanced CT (CECT), and histopathological examination. CRC diagnosis was similarly established through colonoscopy, imaging, and tissue biopsy.
Results: The cohort included 77 males (63.1%) and 45 females (36.9%), with a mean age at diagnosis of 47 ± 11 years. Pancolitis was the most prevalent disease pattern (67.2%), followed by proctosigmoiditis (16.4%). Most patients presented with moderate-to-severe disease activity, with 54.1% having Mayo 3 scores and 49.2% having MES 3. Over the study period, 9 patients (7.4%) developed CRC 6 males and 3 females all of whom had long-standing pancolitis and severe endoscopic inflammation (MES 3).
Conclusion: This North Karnataka cohort demonstrated a predominance of extensive and severe UC. Colonic malignancy occurred exclusively in patients with long-standing pancolitis and high inflammatory burden. These findings highlight the importance of early inflammation control and long-term surveillance in high-risk UC populations.
Downloads
References
1. Amarapurkar DN, et al. Clinical profile of ulcerative colitis in India: a multicenter study. Indian J Gastroenterol. 2002;21:193–195.
2. Sood A, et al. Epidemiology and clinical profile of inflammatory bowel disease in North India. Indian J Gastroenterol. 2003;22:89–94.
3. IOCC Study Group. Clinical characteristics of inflammatory bowel disease in Indian Ocean nations. JGH Open. 2020;4:123–131.
4. Ekbom A, et al. Ulcerative colitis and colorectal cancer: a population-based study. N Engl J Med. 1990;323:1228–1233.
5. Jess T, et al. Risk of colorectal cancer in ulcerative colitis: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10:639–645.
6. Rutter MD, et al. Severity of inflammation predicts colorectal neoplasia in ulcerative colitis. Gut. 2004;53:256–261.
7. Rubin DT, et al. ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol. 2019;114:384–413.
8. Makharia GK, et al. Long-term risk of colorectal cancer in ulcerative colitis: Indian experience. Trop Gastroenterol. 2014;35:25–29.
9. Choi C-HR, et al. Age-related risk of colorectal cancer in ulcerative colitis: updated insights. Nat Rev Gastroenterol Hepatol. 2017;14:653–663
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
